Market Cap (In INR)
541.01 Million
Revenue (In INR)
672.8 Million
Net Income (In INR)
14.61 Million
Avg. Volume
5464.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 10.45-56.5
- PE
- -
- EPS
- -
- Beta Value
- 1.3200741
- ISIN
- INE751D01014
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Umesh Bhaskar Sandu
- Employee Count
- -
- Website
- http://www.sandu.in
- Ipo Date
- 2002-01-03
- Details
- Sandu Pharmaceuticals Ltd. engages in the manufacture and marketing of Ayurvedic medicines. It offers its products under the Berbenteron suspension, Berbenteron tablets, Bilagyl, Debix, Elegance Oil, Ephenin, Haemol Forte, Madiphal Rasayan, Osteon D, Pregutero, Sarak, Shatari, Stresan, Jaundex, Vanari Kalpa, Vimfix, Whoopin and Pentazyme brands. The company was founded on May 10, 1899 and is headquartered in Mumbai, India.
More Stocks
-
PEBBThe Pebble Group plc
PEBB
-
4921Fancl Corporation
4921
-
3591
-
CDEV
-
DESPDespegar.com, Corp.
DESP
-
ARZTYARYZTA AG
ARZTY
-
AHLEASTAsian Hotels (East) Limited
AHLEAST
-
601069